Article Information
History
- January 11, 2022.
Article Versions
- Version 1 (March 1, 2021 - 17:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Valentin Wucher1,2,3,4,7,
- Reza Sodaei1,7,
- Raziel Amador1,
- Manuel Irimia1,5,6,8 and
- Roderic Guigó1,5,8
- 1Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain
- 2NeuroMyogene Institute, SynatAc Team, INSERM U1217/UMR CNRS 5310, Lyon, France
- 3French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France
- 4University of Lyon, Université Claude Bernard Lyon 1, Lyon, France
- 5Universitat Pompeu Fabra, Barcelona, Spain
- 6ICREA, Barcelona, Spain
- ↵8Corresponding authors. Manuel Irimia
, Centre for Genomic Regulation, Dr. Aiguader, 88, 08003 Barcelona, Spain, e-mail: mirimia{at}gmail.com, Phone: +34933160212, Fax: +34933160099, Roderic Guigó
, Centre for Genomic Regulation, Dr. Aiguader, 88, 08003 Barcelona, Spain, e-mail: roderic.guigo{at}crg.eu, Phone: +34933160168, Fax: +34933160099
Posted January 11, 2022.
